Fulgent Genetics Reports Fourth Quarter and Full Year 2019 Financial Results
Fulgent Genetics, Inc. (FLGT)
Last fulgent genetics, inc. earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.fulgentgenetics.com
Company Research
Source: GlobeNewswire
Fourth Quarter 2019 Results: Revenue totals $8.4 million, growing 48% year over yearBillable tests delivered total 13,977, growing 118% year over yearGross Margin improves more than 5 percentage points year over year; cost per test improves approximately 40% year over yearGAAP loss of $296,000, or $0.01 per shareNon-GAAP income of $778,000, or $0.04 per shareAdjusted EBITDA of $1.1 million Full Year 2019 Results: Revenue totals $32.5 million, growing 52% year over yearBillable tests delivered total 58,573, growing 163% year over yearGross Margin improves more than 7 percentage points year over year; cost per test improves approximately 50% year over yearGAAP loss of $411,000, or $0.02 per shareNon-GAAP income of $3.6 million, or $0.19 per shareCash flow from operations of positive $5.5 millionAdjusted EBITDA of $4.9 million TEMPLE CITY, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive ge
Show less
Read more
Impact Snapshot
Event Time:
FLGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FLGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FLGT alerts
High impacting Fulgent Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
FLGT
News
- Global $5.4 Billion Carrier Screening Market, 2024-2028: Analysis by Product & Service, Type, Technology, Medical Condition, End-user, and Region [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024Business Wire
- Fulgent Genetics (NASDAQ:FLGT) shareholders have earned a 26% CAGR over the last five years [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics, Inc. (NASDAQ: FLGT) had its price target lowered by analysts at Piper Sandler from $28.00 to $25.00. They now have a "neutral" rating on the stock.MarketBeat
- An Intrinsic Calculation For Fulgent Genetics, Inc. (NASDAQ:FLGT) Suggests It's 32% Undervalued [Yahoo! Finance]Yahoo! Finance
FLGT
Earnings
- 2/28/24 - Beat
FLGT
Sec Filings
- 4/30/24 - Form 4
- 4/30/24 - Form 4
- 4/30/24 - Form 4
- FLGT's page on the SEC website